Strophanthus
Ouabain · g-Strophanthin · Strophanthin · k-Strophanthin · Strophanthus gratus · Strophanthus kombe
Snapshot
| Indications | Contraindications |
|---|---|
Strophanthus refers to African climbing plants, including Strophanthus gratus, whose seeds yield ouabain (g-strophanthin), a rapid-acting cardiac glycoside that inhibits the sodium pump1. That cardiotonic action drives interest in heart failure and atrial fibrillation, uses that rest on digitalis pharmacology rather than on trials of Strophanthus products1. Strophanthus hispidus extracts also showed antimicrobial, antioxidant, and wound-healing activity in laboratory and excision-wound models.
A 2025 randomized trial in atrial fibrillation with heart failure found digoxin improved functional outcomes over beta-blockers, and circulating cardiotonic steroids, including low ouabain levels, did not alter that response4. A 2011 dose-finding trial of rostafuroxin, an antagonist of endogenous ouabain, found no blood pressure reduction at any dose5. In transfected cell lines, a 2021 study found familial hemiplegic migraine mutations in the sodium pump gene lowered ouabain-sensitive pump activity; no human trial has tested ouabain in migraine. Ouabain serves mainly as the standard research tool for cardiotonic steroids rather than a defined supplement form; see Form comparison.
A 2018 review describes a very narrow therapeutic window for digitalis glycosides, with serum digoxin levels monitored closely1.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
38 sources, 32 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
Sources
- 1Clinical Use of Digitalis: A State of the Art Review.pubmed.ncbi.nlm.nih.govWhayne · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2018 · Pubmed
- 2Antimicrobial, Antioxidant, and Wound Healing Properties of Kigelia africana (Lam.) Beneth. and Strophanthus hispidus DC.pubmed.ncbi.nlm.nih.govAgyare, Dwobeng, Agyepong et al. · Advances in pharmacological sciences · 2013 · Pubmed
- 3On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.pubmed.ncbi.nlm.nih.govVenugopal, Blanco · Molecules (Basel, Switzerland) · 2017 · Pubmed
- 4Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure.pubmed.ncbi.nlm.nih.govAkoumianakis, Gilligan, Bunting et al. · BMC medicine · 2025 · Pubmed
- 5Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.pubmed.ncbi.nlm.nih.govStaessen, Thijs, Stolarz-Skrzypek et al. · Trials · 2011 · Pubmed